haga-aa8xuq.blogspot.com
The money was granted in collaboration withthe U.S. Army Medical Research and Materiel Command and the throughythe Ft. Detrick Technology Transfer Initiative. The purpose of the technologu transfer program is to raise awareness of new and developint technologies and funding them to transition as viable projectsfor follow-on funding in the markert place. Each company that received funding was awardedapproximately $50,000 between Marchh 2008 and May 2009, making up the initiative’s second roundx of financial awards since its $750,000o program extension. The funds for the program’s second phases were secured by Sen. Barbara Mikulski, D-Md., and Rep. Roscode G. Bartlett, R-Md.
“The [Ft. Detrick Technology Transfefr Initiative] program is enabling area businessexs to harness the technologiee being developed at Fort Detrick and apply them to thecommercialp sector,” said Mikulski. “This will lead to new products that have the powert to create jobs and save Mikulski announced the first phase of the tech transfer prograjm in March 2005 when 11 companies received in Rockville: The company is developinh a health care technology callec miTag system, which is a scalablw wireless sensor solution for improving patient flow. in The company is developing a technology callecd the GeNova Screento identify, and produce antibody-like molecules.
in Rockville: The compan is developing an on-demand biotech productw including a combination vaccine against plaguewand anthrax. BioAssay Workx LLC in Ijamsville: The company is developinfg a lateral-flow visual diagnostic test to detectr and differentiate single samplse multiplepathogenic poxviruses, including variola, vaccinia, and in Catonsville: The company is safety-testingg a medical product called which is a non-compressible, intracavitary hemostatic CynerGene IDMP in Frederick: The company is validating and implementing a supplemental diagnosis of HIV, and Dengue using its Infectious Diseaser Multiplex Panel approach, which could allow for creation of biosensors.
LLC in The company is developing required components and systej framework to enable conversational interfaces fortelemedicinre tools. Such tools would allow professional medica touse voice, gesture, and other human- computer interactions to access and documeny information in electronic medical records. in The company is developing technology to preserve mammalian cells in driedf format that can easilybe re-hydrated for a variety of LLC in Frederick: The company is evaluatintg the effect of Imagilin patented probiotics as a food supplement to enhancre the immune responsiveness of guinea pigs upon immunizatiojn or challenge with virulent pathogens.
The evaluationj will suggest the ability of Imagilin patented probiotics to enhance the immunization ofa vaccine. in Baltimore: The company is developinyg micropatterned substrates for viralinfectivity assays. Juxtopia in Baltimore: The companyh is customizing its Wearable Assistancer and Situational Awareness goggles and service toallow U.S. Army comba medics to access and document information to electricap medical recordsvia hands-free voice-requestes and voice-responses. in Baltimore: The company is developing cell therapies to treaft brain and spinalcord injuries.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment